Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: CALGB A051202 Principal Investigator: Bartlett, Nancy
Title: A Phase I Trial of Lenalidomide, Rituximab, and Idelalisib in Recurrent Follicular Lymphoma
Phase: I Disease Site: Non-Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test the safety of the combination of the drugs lenalidomide and idelalisib at different dose levels, in combination with the drug rituximab; to find out the effects (good and/or bad) they have on the patient and their follicular lymphoma.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)